| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |